Mobile Phone Messaging During Unobserved "Home" Induction to Buprenorphine.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 26933874.
- Also identified by DOI 10.1097/ADM.0000000000000198.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The deployment of health information technologies promises to optimize clinical outcomes for populations with substance use disorders. Electronic health records, web-based counseling interventions, and mobile phone applications enhance the delivery of evidence-based behavioral and pharmacological treatments, with minimal burden to clinical personnel, infrastructure, and work flows. This clinical case shares a recent experience utilizing mobile phone text messaging between an office-based buprenorphine provider in a safety net ambulatory clinic and a patient seeking buprenorphine treatment for opioid use disorder. The case highlights the use of text message-based physician-patient communication to facilitate unobserved "home" induction onto buprenorphine.
Medical subject headings
- Buprenorphine
- Heroin Dependence
- Narcotic Antagonists
- Opiate Substitution Treatment
- Text Messaging